EUVIMEDEUVIMED entdecken
Open Access

Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin

Joseph W Po, Aflah Roohullah, David Lynch, Anna DeFazio, Michelle Harrison, Paul R Harnett, Catherine Kennedy, Paul de Souza, Therese M Becker

Journal of Circulating Biomarkers · 2018

DOI: 10.1177/1849454418782617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Circulating Biomarkers, 2018. Verfasst von Joseph W Po und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial cell adhesion molecule (EpCAM)-targeted capture remains the most common isolation strategy for circulating tumor cells (CTCs). However, epithelial-to-mesenchymal transition (EMT) leads to decreased epithelial EpCAM expression affecting the optimal CTC capture. In this study, we tested a cohort of ovarian cancer cell lines using flow cytometry to identify N-cadherin as the additional immunomagnetic cell surface target for ovarian cancer cell isolation. Combined immunomagnetic targeting of mesenchymal N-cadherin and epithelial EpCAM enriched CTCs from advanced ovarian cancer patient blood approximately three times more efficiently than targeting of EpCAM alone. We also show that more EMT-phenotype CTCs are captured by including N-cadherin targeting into CTC isolation protocols. However, after N-cadherin-based CTC isolation, in some blood samples of healthy individuals, we also observed the presence of cells expressing markers common to CTCs. Our data show that these "false positives" can be largely distinguished from CTCs as circulating endothelial cells (CECs) by vascular endothelial-cadherin co-staining. CEC counts are highly variable in patients and healthy controls. Our data demonstrate that a combination of EpCAM with N-cadherin-targeted isolation can improve CTC detection and widen the EMT-phenotype spectrum of captured CTCs.

Schlagwörter

Stichwörter der Autor:innen

CTCEMTEpCAMN-cadherinVE-cadherinvimentin

Autor:innen und Institutionen

  • Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
  • School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.
  • Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia.
  • Centre for Cancer Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
  • The University of Sydney, New South Wales, Australia.
  • The Crown Princess Mary Cancer Centre Westmead, Westmead Hospital, New South Wales, Australia.

Zitieren

APA

Po, J. W., Roohullah, A., Lynch, D., DeFazio, A., Harrison, M., Harnett, P. R., Kennedy, C., de Souza, P., & Becker, T. M. (2018). Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin. Journal of Circulating Biomarkers. https://doi.org/10.1177/1849454418782617

Vancouver

Po JW, Roohullah A, Lynch D, DeFazio A, Harrison M, Harnett PR, et al. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin. Journal of Circulating Biomarkers. 2018. doi:10.1177/1849454418782617

BibTeX
@article{Po2018,
  author = {Po, Joseph W and Roohullah, Aflah and Lynch, David and DeFazio, Anna and Harrison, Michelle and Harnett, Paul R and Kennedy, Catherine and de Souza, Paul and Becker, Therese M},
  title = {Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin},
  journal = {Journal of Circulating Biomarkers},
  year = {2018},
  doi = {10.1177/1849454418782617}
}
Kostenlos starten →